Inhibition of ribonucleotide reductase by antitumor agents related to levodopa and dopamine
- 1 February 1985
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 34 (3) , 353-360
- https://doi.org/10.1016/0006-2952(85)90043-7
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- 3,4-Dihydroxybenzylamine: An Improved Dopamine Analog Cytotoxic for Melanoma Cells in Part Through Oxidation Products Inhibitory to DNA PolymeraseJournal of Investigative Dermatology, 1983
- Regulation of ribonucleotide reductase in mammalian cells by chemotherapeutic agentsAdvances in Enzyme Regulation, 1981
- Inhibition of reverse transcriptase by tyrosinase generated quinones related to levodopa and dopamineChemico-Biological Interactions, 1981
- N-Carbamoyloxyurea-resistant Chinese hamster ovary cells with elevated levels of ribonucleotide reductase activityJournal of Cellular Physiology, 1981
- Dopamine: A Novel Antitumor Agent Active Against B-16 Melanoma In VivoJournal of Investigative Dermatology, 1978
- A permeable animal cell preparation for studying macromolecular synthesis. DNA synthesis and the role of deoxyribonucleotides in S phase initiationBiochemistry, 1978
- L-Dopa methyl ester as a new antitumour agentNature, 1977
- A rapid assay for CDP reductase activity in mammalian cell extractsAnalytical Biochemistry, 1970
- The response in vitro, of continuous cultures of human lymphoblasts (CCRF-CEM cells) to chemotherapeutic agentsBiochemical Pharmacology, 1967
- Kinetics of Regulatory EnzymesPublished by Elsevier ,1965